FDA

Dr. Vincent Hsu, an epidemiologist and AdventHealth’s infection control officer, discusses the vaccine, complications and why people should still keep getting vaccinated.

Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.

Gov. Ron DeSantis called the pause in administering the Johnson & Johnson vaccine a "speed bump," while acknowledging the state would follow the federal recommendation.

The Food and Drug Administration says Abbott's BinaxNOW test and Quidel's QuickVue can be sold without a prescription.

Updated study results say the vaccine is 76% effective against symptomatic COVID-19 and 100% effective against severe disease. Independent monitors had been concerned about a previous report.

NPR's Scott Simon asks FDA adviser Dr. Paul Offit about Johnson & Johnson's vaccine and other developments in the pandemic.

The FDA released an analysis of Johnson & Johnson's COVID-19 vaccine Wednesday morning that appears to support its authorization for emergency use.

The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.

Agency officials said reducing the number of doses creates a potential for harm in patients because "they may assume that they are fully protected when they are not" and may "take unnecessary risks."

The FDA greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.